AVTR
Avantor, Inc.
NYSE · Healthcare · Medical - Instruments & Supplies · US
$16.68
−0.06%Oct 28, 2026, 12:51 UTC
Avantor reported quarterly earnings of $0.22 per share, above the Zacks Investment Research, Inc. consensus estimate of $0.21 per share.
Source:Oct 28, 2026, 10:46 UTC
Avantor reported third-quarter 2026 revenue of $1.6983 billion and net income of $203.4 million, and provided fiscal 2026 revenue guidance of $1.698 billion to $1.703 billion and diluted EPS guidance of $0.81 to $0.83.
Oct 28, 2026, 10:05 UTC
Avantor reported third-quarter 2026 net sales of $1,698.3 million, up 4.6% (5.2% organically), diluted GAAP EPS of $0.30 and adjusted EPS of $0.22.
Source:Oct 28, 2026, 10:05 UTC
Avantor raised its fiscal 2026 guidance for organic revenue growth, adjusted EPS and free cash flow.
Source:Oct 15, 2026, 20:06 UTC
AbbVie appointed John M. Carethers as a Class II director, effective October 14, 2026.
Oct 1, 2026, 10:05 UTC
Avantor, Inc. announced it will release its third quarter 2026 financial results before market open on October 28, 2026, and hold a conference call the same day.
Source:Sep 21, 2026, 11:10 UTC
Avantor, Inc. changed Steven Eck's role to Senior Vice President and Chief Accounting Officer, effective September 21, 2026.
Sep 21, 2026, 11:10 UTC
Avantor, Inc. appointed Todd Garner as Executive Vice President and Chief Financial Officer, effective September 21, 2026.
Sep 18, 2026, 14:31 UTC
Avantor expanded its RIM single-use bioprocessing portfolio across the Asia-Pacific region, increasing access to locally made bioprocessing solutions.
Source:Sep 8, 2026, 17:59 UTC
My Green Lab announced that more than 15 laboratory product distributors, procurement platforms, and laboratory analytics platforms have joined its ACT Ecolabel Channel Partner network to integrate independently verified sustainability data into purchasing workflows.
Source:Aug 22, 2026, 07:12 UTC
Advisors Capital Management LLC disclosed a new minority stake in Avantor, Inc. by purchasing 441,317 shares worth approximately $4.37 million during the second quarter, according to its 13F filing.
Source:Jul 29, 2026, 10:05 UTC
Avantor, Inc. reported its second quarter 2026 financial results on July 29, 2026, with net sales of $1,692.3 million, net income of $38.1 million, adjusted EBITDA of $254.3 million, diluted GAAP EPS of $0.06, adjusted EPS of $0.21, operating cash flow of $178.2 million, and free cash flow of $142.8 million.
Jul 17, 2026, 00:00 UTC
Avantor, Inc. amended its 2017 credit agreement to add a €374.2 million tranche of Incremental B-7 Euro Term Loans, refinancing existing senior secured euro term loans and reducing the interest rate spread from 2.50% to 2.00% over EURIBOR, with the maturity date retained as October 9, 2032.
Jul 15, 2026, 14:05 UTC
NuSil expands its HIV prevention partnership for a three-month dapivirine vaginal ring.
Source: